Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Commercial
  • The first 14 days: How specialty programs set patients up for success
  • Commercial

The first 14 days: How specialty programs set patients up for success

BioPharma Dive

As specialty medicines play a growing role in healthcare, the patient journey that follows is equally critical.

Read full story

pharminent June 22, 2026 (Last updated: June 22, 2026)

BioPharma Dive

As specialty medicines play a growing role in healthcare, the patient journey that follows is equally critical.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Japan approves Sanofi’s Sarclisa combo for MM treatment
Next: Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Related Stories

  • Commercial

Wegovy pill launches in UK as first daily oral GLP1 for weight management

pharminent July 6, 2026
  • Commercial

Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval

pharminent June 26, 2026
  • Commercial

Lilly launches its LillyDirect sales channel in the UK

pharminent June 25, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.